Literature DB >> 9461512

Dephosphorylation of Ser-137 in DARPP-32 by protein phosphatases 2A and 2C: different roles in vitro and in striatonigral neurons.

F Desdouits1, J C Siciliano, A C Nairn, P Greengard, J A Girault.   

Abstract

DARPP-32 (dopamine- and cAMP-regulated phosphoprotein, Mr=32000) is highly expressed in striatonigral neurons in which its phosphorylation is regulated by several neurotransmitters including dopamine and glutamate. DARPP-32 becomes a potent inhibitor of protein phosphatase 1 when it is phosphorylated on Thr-34 by cAMP- or cGMP-dependent protein kinases. DARPP-32 is also phosphorylated on Ser-137 by protein kinase CK1 (CK1), in vitro and in vivo. This phosphorylation has an important regulatory role since it inhibits the dephosphorylation of Thr-34 by calcineurin in vitro and in striatonigral neurons. Here, we show that DARPP-32 phosphorylated by CK1 is a substrate in vitro for protein phosphatases 2A and 2C, but not protein phosphatase 1 or calcineurin. However, in substantia nigra slices, dephosphorylation of Ser-137 was markedly sensitive to decreased temperature, and not detectably affected by the presence of okadaic acid under conditions in which dephosphorylation of Thr-34 by protein phosphatase 2A was inhibited. These results suggest that, in neurons, phospho-Ser-137-DARPP-32 is dephosphorylated by protein phosphatase 2C, but not 2A. Thus, DARPP-32 appears to be a component of a regulatory cascade of phosphatases in which dephosphorylation of Ser-136 by protein phosphatase 2C facilitates dephosphorylation of Thr-34 by calcineurin, removing the cyclic nucleotide-induced inhibition of protein phosphatase 1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461512      PMCID: PMC1219129          DOI: 10.1042/bj3300211

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

Review 1.  Role of cAMP in cyclic cascade regulation.

Authors:  E Shacter; E R Stadtman; S R Jurgensen; P B Chock
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

2.  Protein phosphatase-2C from rabbit skeletal muscle and liver: an Mg2+-dependent enzyme.

Authors:  C H McGowan; P Cohen
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle.

Authors:  P Cohen; S Alemany; B A Hemmings; T J Resink; P Strålfors; H Y Tung
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

4.  DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1.

Authors:  H C Hemmings; P Greengard; H Y Tung; P Cohen
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

5.  Protein phosphatases active on acetyl-CoA carboxylase phosphorylated by casein kinase I, casein kinase II and the cAMP-dependent protein kinase.

Authors:  L A Witters; G W Bacon
Journal:  Biochem Biophys Res Commun       Date:  1985-08-15       Impact factor: 3.575

6.  A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions.

Authors:  S I Walaas; D W Aswad; P Greengard
Journal:  Nature       Date:  1983-01-06       Impact factor: 49.962

7.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. II. Purification and characterization of the phosphoprotein from bovine caudate nucleus.

Authors:  H C Hemmings; A C Nairn; D W Aswad; P Greengard
Journal:  J Neurosci       Date:  1984-01       Impact factor: 6.167

8.  Identification of protein phosphatase 2A as the major tyrosine hydroxylase phosphatase in adrenal medulla and corpus striatum: evidence from the effects of okadaic acid.

Authors:  J Haavik; D L Schelling; D G Campbell; K K Andersson; T Flatmark; P Cohen
Journal:  FEBS Lett       Date:  1989-07-17       Impact factor: 4.124

9.  Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II.

Authors:  J A Girault; H C Hemmings; K R Williams; A C Nairn; P Greengard
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

10.  Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra.

Authors:  K Tsou; G L Snyder; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more
  10 in total

1.  Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3.

Authors:  Marc Flajolet; Sergey Rakhilin; Hong Wang; Natalia Starkova; Nina Nuangchamnong; Angus C Nairn; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

2.  Discovery of protein phosphatase 2C inhibitors by virtual screening.

Authors:  Jessica P Rogers; Albert E Beuscher; Marc Flajolet; Thomas McAvoy; Angus C Nairn; Arthur J Olson; Paul Greengard
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

3.  Dopamine-dependent tuning of striatal inhibitory synaptogenesis.

Authors:  Darren Goffin; Afia B Ali; Nazir Rampersaud; Alexander Harkavyi; Celine Fuchs; Peter S Whitton; Angus C Nairn; Jasmina N Jovanovic
Journal:  J Neurosci       Date:  2010-02-24       Impact factor: 6.167

4.  Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution.

Authors:  Akinori Nishi; Miriam Matamales; Veronica Musante; Emmanuel Valjent; Mahomi Kuroiwa; Yosuke Kitahara; Heike Rebholz; Paul Greengard; Jean-Antoine Girault; Angus C Nairn
Journal:  J Biol Chem       Date:  2016-12-20       Impact factor: 5.157

5.  Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals.

Authors:  J N Jovanovic; T S Sihra; A C Nairn; H C Hemmings; P Greengard; A J Czernik
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

Review 6.  Effects of nicotine on DARPP-32 and CaMKII signaling relevant to addiction.

Authors:  Angela M Lee; Marina R Picciotto
Journal:  Adv Pharmacol       Date:  2020-10-06

7.  DARPP-32, Jack of All Trades… Master of Which?

Authors:  Marion Yger; Jean-Antoine Girault
Journal:  Front Behav Neurosci       Date:  2011-09-08       Impact factor: 3.558

Review 8.  DARPP-32: from neurotransmission to cancer.

Authors:  Abbes Belkhiri; Shoumin Zhu; Wael El-Rifai
Journal:  Oncotarget       Date:  2016-04-05

9.  A kinetic model of dopamine- and calcium-dependent striatal synaptic plasticity.

Authors:  Takashi Nakano; Tomokazu Doi; Junichiro Yoshimoto; Kenji Doya
Journal:  PLoS Comput Biol       Date:  2010-02-12       Impact factor: 4.475

Review 10.  Neuronal circuits and physiological roles of the basal ganglia in terms of transmitters, receptors and related disorders.

Authors:  Katsuya Yamada; Susumu Takahashi; Fuyuki Karube; Fumino Fujiyama; Kazuto Kobayashi; Akinori Nishi; Toshihiko Momiyama
Journal:  J Physiol Sci       Date:  2016-03-15       Impact factor: 2.781

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.